As US reopens, campuses tighten restrictions for virus

About a year into mask mandates, nasal swabs and remote classes, the atmosphere turned tense at the University of Vermont as the school cracked down on rules for social distancing and face coverings amid a spike in student COVID-19 cases.

States scale back vaccine orders as interest in shots wanes

States asked the federal government this week to withhold staggering amounts of COVID-19 vaccine amid plummeting demand for the shots, contributing to a growing U.S. stockpile of doses.

Major US pipeline targeted in cyber attack

The largest fuel pipeline system in the United States was forced to shut down its entire network after a cyber attack, the company said in a statement.

EU says US stand on patent virus waiver is no 'magic bullet'

European Union leaders cranked up their criticism of the U.S. call to waive COVID-19 vaccine patents Saturday, arguing the move would yield no short-term or intermediate improvement in vaccine supplies and could even have a negative impact.

Archaeologists discover remains of 9 Neanderthals near Rome

Italian archaeologists have uncovered the fossilized remains of nine Neanderthals in a cave near Rome, shedding new light on how the Italian peninsula was populated and under what environmental conditions.

Switch of breast tumors to HER2-low in recurrence may provide greater therapeutic options

The finding that breast tumours can evolve to express low HER2 potentially widens the number of patients who can benefit from new investigational agents, typically novel antibody-drug conjugate therapies, that are currently in clinical trials for HER2-low tumours.

Ingenuity Mars helicopter completes first one-way trip

NASA's Ingenuity Mars Helicopter completed its fifth flight on the Red Planet today with its first one-way journey from Wright Brothers Field to an airfield 423 feet (129 meters) to the south. After arrival above its new airfield, Ingenuity climbed to an altitude record of 33 feet (10 meters) and captured high-resolution color images of its new neighborhood before touching down.

3D printing company Desktop Metal will now use wood to print

The 3D printing company Desktop Metal has just announced the release of Forust, a new tool using wood to 3D print objects. The company, founded in 2019, focuses on 3D printing for interior design. With printing methods deemed "non-destructive", they haven't come under much scrutiny for safety or environmental concerns, making them an attractive prospect for acquisition.

EU seals deal for up to 1.8 bn extra BioNTech/Pfizer doses

The EU has concluded a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of its COVID-19 vaccine, European Commission chief Ursula von der Leyen said on Saturday.

Last wild macaw in Rio is lonely and looking for love

Some have claimed she's indulging a forbidden romance. More likely, loneliness compels her to seek company at Rio de Janeiro's zoo.

After lull, cases spread in Vietnam's cities, provinces

After over a month with no local infections, Vietnam has recorded 176 confirmed coronavirus cases from several outbreaks that have spread to 19 provinces during the past 10 days, the Health Ministry said.

California agency approves warehouse rule for air quality

Southern California air quality regulators on Friday approved a rule that would curb diesel emissions from thousands of trucks that ferry goods from the growing number of massive warehouses in the region run by Amazon and other companies.

Thailand wants to buy more vaccines as surge worsens

Thailand's prime minister said he wants to secure more vaccines for his country and give as many first doses as possible, as it battles a surge of the pandemic with Bangkok reporting a record number of cases.

EXPLAINER: How activists target CDC vaccine tracking system

Once, getting vaccinated was all but routine. But since the heightened public awareness around the new COVID-19 vaccines, it's a different story. Now, it means check-ins with family and friends about possible arm soreness or mild symptoms.

Online speech shield under fire as Trump Facebook ban stays

Lurking beneath Facebook's decision on whether to continue Donald Trump's suspension from its platform is a far more complex and consequential question: Do the protections carved out for companies when the internet was in its infancy 25 years ago make sense when some of them have become global powerhouses with almost unlimited reach?

Facebook winning war on COVID vaccine lies, hoaxes and conspiracies. Twitter and TikTok? Not so much, report says

The nation's leading social media companies pledged to put warning labels on COVID-19 and COVID vaccines posts to stop the spread of falsehoods, conspiracy theories and hoaxes that are fueling vaccine hesitancy in the U.S..

Chinese rocket to tumble back to Earth in uncontrolled re-entry

A large segment of a Chinese rocket is expected to make an uncontrolled re-entry into the Earth's atmosphere on the weekend, but Beijing has downplayed fears and said there is a very low risk of any damage.

In fight against COVID variants some firms target T cell jabs

Getting COVID vaccines into the arms of the world's population is an international priority—but will today's jabs stay effective against virus variants that are spreading across the globe?

Virus deaths top 4,000 in India as WHO green-lights Chinese vaccine

New COVID-19 deaths surged past 4,000 for the first time in India on Saturday as it struggled with one of the world's worst outbreaks, but the global immunisation effort was boosted with WHO approval for Chinese firm Sinopharm's vaccine.

EU seeks 'concrete' US plan on lifting vaccine patents

EU chief Charles Michel said the bloc is ready to discuss a US proposal to lift patents on COVID-19 vaccines once the details are clear.

India's surge hits southern states, prompts more lockdowns

Two southern states in India became the latest to declare lockdowns, as coronavirus cases surge at breakneck speed across the country and pressure mounts on Prime Minister Narendra Modi's government to implement a nationwide shutdown.

Mild COVID-19 infection is very unlikely to cause lasting heart damage

Mild Covid-19 infection is very unlikely to cause lasting damage to the structure or function of the heart, according to a study led by UCL (University College London) researchers and funded by the British Heart Foundation (BHF) and Barts Charity.

Largest study to date confirms non-steroidal anti-inflammatory medications do not result in worse COVID-19 outcomes

The use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, does not lead to higher rates of death or severe disease in patients who are hospitalised with COVID-19, according to a new observational study of more than 72,000 people in the UK published in The Lancet Rheumatology journal.